Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer

Gut

Volumn 58, Issue 10, 2009, Pages 1410-1418

  Langer, P ^a   Kann, P H ^a   Fendrich, V ^a   Habbe, N ^a   Schneider, M ^a   Sina, M ^a   Slater, E P ^a   Heverhagen, J T ^a   Gress, T M ^a   Rothmund, M ^a   Bartsch, D K ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER SCREENING; CLINICAL EXAMINATION; CYSTIC FIBROSIS; CYTOLOGY; ENDOSCOPIC ECHOGRAPHY; FAMILIAL CANCER; FAMILY COUNSELING; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LABORATORY TEST; LAPAROTOMY; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGE DISTRIBUTION; EARLY DETECTION OF CANCER; ENDOSONOGRAPHY; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERMANY; HUMANS; MALE; PANCREATIC NEOPLASMS; PEDIGREE; RISK ASSESSMENT;

EID: 70349318044     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.171611     Document Type: Article

References (33)

1. Cooperman AM. Pancreatic cancer: the bigger picture. Surg Clin North Am 2001;81:557-574
2. Cleary SP, Gryfe R, Guindi M, et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 2004;198:722-731 (Pubitemid 38542900)
3. Furukawa H, Okada S, Saisho H, et al. Clinicopathologic features of small pancreatic adenocarcinoma: a collective study. Cancer 1996;78:986-990 (Pubitemid 26284862)
4. Tersmette AC, Petersen GM, Offerhaus GJ, et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 2001;7:738-744 (Pubitemid 32708001)
5. Klein AP, Brune KA, Petersen GM, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004;64:2634-2638 (Pubitemid 38523922)
6. Rulyak SJ, Lowenfels AB, Maisonneuve P, et al. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 2003;124:1292-1299 (Pubitemid 36531804)
7. Ghadirian P, Boyle P, Simard A, et al. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol 1991;10:183-196
8. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004;1:e65. (Pubitemid 40418886)
9. Hruban RH, Maitra A, Kern SE, et al. Precursors to pancreatic cancer. Gastroenterol Clin North Am 2007;36:831-849
10. Brentnall TA, Bronner MP, Byrd DR, et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999;131:247-255 (Pubitemid 29383653)
11. Kimmey MB, Bronner MP, Byrd DR, et al. Screening and surveillance for hereditary pancreatic cancer. Gastrointest Endosc 2002;56:S82-6.
12. Canto MI, Goggins M, Yeo CJ, et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2004;2:606-621 (Pubitemid 38834045)
13. Canto MI, Goggins M, Hruban RH, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006;4:766-781 (Pubitemid 43825802)
14. Brand R, Rubinstein C, Lerch MM, et al. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007;56:1460-1469 (Pubitemid 47517845)
15. Rieder H, Sina-Frey M, Ziegler A, et al. German national case collection of familial pancreatic cancer-clinical-genetic analysis of the first 21 families. Onkologie 2002;25:262-266 (Pubitemid 34765273)
16. Bartsch DK, Kress R, Sina-Frey M. Prevalence of familial pancreatic cancer in Germany. Int J Cancer 2004;110:902-906 (Pubitemid 38758518)
17. Lynch HT, Lanspa SJ, Fitzgibbons RJ Jr, et al. Familial pancreatic cancer (part 1): genetic pathology review. Nebr Med J 1989;74:109-112
18. Kann PH, Ivan D, Pfützner A, et al. Preoperative diagnosis of insulinoma: low body mass index, young age, and female gender are associated with negative imaging by endoscopic ultrasound. Eur J Endocrinol 2007;157:209-213 (Pubitemid 47233126)
19. Wiersema MJ, Hawes RH, Lehman GA, et al. Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin. Endoscopy 1993;25:555-564
20. Jenssen C, Dietrich CF. Endoscopic ultrasound in chronic pancreatitis. Z Gastroenterol 2005;43:737-749
21. Detlefsen S, Sipos B, Feyerabend B, et al. Pancreatic fibrosis associated with age and ductal papillary hyperplasia. Virchows Arch 2005;447:800-805 (Pubitemid 41728867)
22. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-596 (Pubitemid 32423354)
23. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004;239:788-797
24. American Gastroenterological Association. Medical Position Statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma Gastroenterology 1999;117:1463-1484
25. Brown ML, Houn F, Sickles EA, et al. Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. Am J Roentgenol 1995;165:1372-1377
26. Rubenstein JH, Scheiman JM, Anderson MA. A clinical and economic evaluation of endoscopic ultrasound for patients at risk for familial pancreatic adenocarcinoma. Pancreatology 2007;7:514-525
27. Canlas KR, Branch MS. Role of endoscopic retrograde cholangiopancreatography in acute pancreatitis. World J Gastroenterol 2007;13:6314-6320
28. Sugiyama M, Haradome H, Atomi Y. Magnetic resonance imaging for diagnosing chronic pancreatitis. J Gastroenterol 2007;42:108-112 (Pubitemid 46140376)
29. Pungpapong S, Wallace MB, Woodward TA, et al. Accuracy of endoscopic ultrasonography and magnetic resonance cholangiopancreatography for the diagnosis of chronic pancreatitis: a prospective comparison study.J Clin Gastroenterol 2007;41:88-93.
30. Heverhagen JT, Burbelko M, Schenck zu Schweinsberg T, et al. Secretin-enhanced magnetic resonance cholangiopancreaticography: value for the diagnosis of chronic pancreatitis. Rofo 2007;179:790-795
31. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001;54:425-434 (Pubitemid 33661145)
32. Sahai AV, Zimmerman M, Aabakken L, et al. Prospective assessment of the ability of endoscopic ultrasound to diagnose, exclude, or establish the severity of chronic pancreatitis found by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc 1998;48:18-25. (Pubitemid 28337423)
33. Abe T, Fukushima N, Brune K, et al. Genome-wide allelotypes of familial pancreatic adenocarcinomas and familial and sporadic intraductal papillary mucinous neoplasms. Clin Cancer Res 2007;13:6019-6025 (Pubitemid 350075057)